Skip to main content
OpenTrials

Clinical trial condition

Progressive Supranuclear Palsy (PSP)

Explore clinical trials studying Progressive Supranuclear Palsy (PSP). Study availability and eligibility vary by location and protocol.

18 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Progressive Supranuclear Palsy (PSP) trial results

Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684

Conditions
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Behavioral Variant Frontotemporal Dementia (bvFTD), +41 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 27 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

NCT04539041

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +20 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Vanderbilt University Medical CenterX Nashville, Tennessee, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Completed

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

NCT02966145

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • University of California, San Diego (UCSD) San Diego, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Harvard University - Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Completed

ADDIA Proof-of-Performance Clinical Study

NCT03030586

Conditions
Alzheimer Disease, Alzheimer Disease (AD), Basal Ganglia Diseases, +31 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • ERASME Hospital Brussels, Belgium
  • Hopitaux Universitaires de Strasbourg Strasbourg, Alsace, France
  • Centre Hospitalier Universitaire de Besançon Besançon, France
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

NCT04193527

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +24 more
Locations
  • Beijing Anzhen Hospital, Capital Medical University Beijing, Chaoyang District, China
  • Peking Union Medical College Hospital Beijing, Dongcheng District, China
  • Nanfang Hospital, Nanfang Medical Univeristy Guangdong, Guangzhou, China
  • Nanjing First Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions